Ophthalmic World Leaders
Mark Your Calendar
OWL Europe Virtual Program: Bridging Cultures
Thursday, December 4, 2025
18:00 CET (12:00 PM EST/9 AM PST)
Join us online and meet Kay Xander Mellish, our dynamic speaker from OWL's Signature Event at ESCRS! Be a part of the discussion as we dig deeper into this fascinating topic. Click to learn more!
SoCal Chapter Holiday Event
Thursday, December 11, 2025
5:30 PM - 7:00 PM
Hosted by: STAAR Surgical
Join OWL's SoCal Chapter for this holiday event as we wind down 2025. Come enjoy fun networking and games, and a tour of STAAR's new Experience Center.
Upcoming Events
Leadership Summit
July 30-31, 2026
OLS 2026
SAVE THE DATE!
OWL's annual Leadership Summit is a staple in the event calendar. Our 5th Leadership Summit will be held July 30-31.
We're working to make next year's Summit our most impactful yet! Save the date to join us in Nashville at the Gaylord Opryland Resort.
Our 2026 program details coming soon!
Check out highlights from OLS 2025. →
Featured Champions
Kevin Douglas, MD
Medical Director
AbbVie
Kevin Douglas, MD is a Biopharmaceutical Executive with close to 20 years of industry expertise, in the U.S and Global markets. He began his career with Sanofi-Aventis as a Regional Medical Science Liaison in their Cardiovascular Division. He then joined UCB as a Medical Science Liaison supporting the launch and FDA approval of CIMZIA for the treatment of Crohn’s Disease and Rheumatoid Arthritis. Transitioning to the UCB global team and relocating to Brussels, Belgium; Kevin served as the Associate Director of UCB’s Global Medical Affairs Gastroenterology Division. He began his tenure with AbbVie in the Fall of 2014, as the first Medical Director for the US Medical Affairs Rheumatology division, where he led the first USMA Phase IV clinical trial study and in 2017 was the Medical Lead for the launch of HUMIRA in noninfectious intermediate, posterior and panuveitis. Kevin currently serves as Medical Director; Retina Lead for USMA Eye Care at Allergan/AbbVie.
Throughout his career, Kevin has remained committed to supporting the development of innovative advanced therapies for some of the world’s most complex and critical conditions.
Saba Kadlec, MD
Executive Director of Clinical Development
Aurion Biotech
Saba is a board-certified ophthalmologist with advanced subspecialty training in Cornea, Anterior Segment, and Refractive Surgery from the Illinois Eye & Ear Infirmary at the University of Illinois–Chicago. She spent over a decade in private practice, where she honed her clinical and surgical expertise before transitioning full-time into the biopharmaceutical industry.
Her industry journey began in Clinical Development at RegenXBio, where she contributed to gene therapy programs targeting neovascular AMD via suprachoroidal delivery. She later consulted for Opthea, supporting development of anti-VEGF C and D agents, before returning to her anterior segment roots at Aurion Biotech. Initially joining as a consultant, she now serves as Executive Director of Clinical Development, leading efforts to advance corneal endothelial cell therapy for patients with endothelial dysfunction.
Outside of work, Saba lives in Milwaukee, Wisconsin, where she’s a proud mother of three. When she’s not cheering from the sidelines at soccer games, she finds joy in book club, travel adventures, and workout classes with friends.